Download PDF
Arzneimittelforschung 2010; 60(8): 471-478
DOI: 10.1055/s-0031-1296314
CNS-active Drugs · Hypnotics · Psychotropics · Sedatives
Editio Cantor Verlag Aulendorf (Germany)

Effect of valproic acid and environmental enrichment on behavioral functions in rats

Krzysztof Kus
Department of Pharmacoeconomics and Social Pharmacy, University of Medical Sciences in Poznan, Poland
,
Kinga Burda
Department of Pharmacoeconomics and Social Pharmacy, University of Medical Sciences in Poznan, Poland
,
Elzbieta Nowakowska
Department of Pharmacoeconomics and Social Pharmacy, University of Medical Sciences in Poznan, Poland
,
Anna Czubak
Department of Pharmacoeconomics and Social Pharmacy, University of Medical Sciences in Poznan, Poland
,
Jana Metelska
Department of Pharmacoeconomics and Social Pharmacy, University of Medical Sciences in Poznan, Poland
,
Michał Łancucki
Department of Pharmacoeconomics and Social Pharmacy, University of Medical Sciences in Poznan, Poland
,
Karolina Brodowska
Department of Pharmacoeconomics and Social Pharmacy, University of Medical Sciences in Poznan, Poland
,
Anna Nowakowska
Department of Pharmacoeconomics and Social Pharmacy, University of Medical Sciences in Poznan, Poland
› Author Affiliations
Further Information

Publication History

Publication Date:
03 December 2011 (online)

    Permissions and Reprints

Abstract

Deficits of cognitive functions are perceived as an important pathogenic factor of many neurological and psychiatric diseases. Such symptoms can be a result of a disease process or appear due to applied medication. Epilepsy is a disease in which cognitive deficits can occur before first seizures, during seizures and remissions. Valproic acid (VAL, CAS 77372-61-3) is a medicine applied in order to control epileptic seizures and mood stabilizing in bipolar disorders and mania. Its activity is related to the effect on neurotransmission of many systems.

The present study was conducted to investigate whether enriched environment (EE) conditions affect learning and memory, and influence the antidepressant effect in rats.

VAL improves spatial memory upon repeated administration both in the rats housed in standard conditions (SC) (after 21 days of treatment) and those housed in enriched environment (as early as after 14 days of treatment). VAL has an antidepressant effect on the forced swimming test both in the rats housed in standard conditions and those housed in EE. In rats housed in EE, the antidepressant effect occurred much earlier (as early as after 7 days of VAL administration). It is worth noting that VAL has a low profile of adverse effects (Activity Meter, chimney test). The correlations observed may be translated into clinical effects, leading to new, more effective VAL therapies in depression or memory disorders in patients with underlying epilepsy.

Key words

Antiepileptic drugs - CAS 77372-61-3 - Enriched environment - Spatial memory - Valproic acid, antidepressant effect
 

  • References

  • 1 Aimone JB, Wiles J, Gage FH. Potential role for adult neurogenesis in the encoding of time in new memories. Nat Neurosci. 2006; 9: 723-7
    CrossrefPubMedGoogle Scholar
  • 2 Aldenkamp AP, Baker G. A systematic review of the effects of lamotrigine on cognitive function and quality of life. Epilepsy Behav. 2001; 2: 85-91
    CrossrefPubMedGoogle Scholar
  • 3 Ben-Menachem E, Schmitz B, Tomson T, Vajda F. Role of valproate across the ages: treatment of epilepsy in adults. Acta Neurol Scand. 2006; 114 (184) 14-27
    PubMedGoogle Scholar
  • 4 Boisser JR, Tardy J, Diverres JC. Une nouvelle méthode simple pour explorer l’action tranquilisante: le test de la cheminée. Med Exp (Basel). 1960; 3: 81-4 French
    PubMedGoogle Scholar
  • 5 Bolanos AR, Sarkisian M, Yang Y, Hori A, Helmers SL, Mikati M et al. Comparison of valproate and phenobarbital treatment after status epilepticus in rats. Neurology. 1998; 51 (1) 41-8
    CrossrefPubMedGoogle Scholar
  • 6 Borowicz KK, Ratnaraj N, Patsalos PN, Czuczwar SJ. Effect of felbamate and its combinations with conventional antiepileptics in amygdala-kindled rats. Pharmacol Biochem Behav. 2004; 78: 103-10
    CrossrefPubMedGoogle Scholar
  • 7 Bowden CL, Singh V. Valproate in bipolar disorder: 2000 onwards. Acta Psychiatr Scand. 2005; 111 (426) 13-20
    CrossrefPubMedGoogle Scholar
  • 8 Boxer CM, Herberg JL, Scott DF. Has sodium valproate hypnoticeffects?. Epilepsia. 1976; 17: 167-70
    PubMedGoogle Scholar
  • 9 Brandt C, Gastens AM, Sun M, Hausknecht M, Loscher W. Treatment with valproate after status epilepticus: effect on neuronal damage, epileptogenesis, and behavioral alterations in rats. Neuropharmacoly. 2006; 51: 789-804
    PubMedGoogle Scholar
  • 10 Brenes JC, RodrÍguez O, Fornaguera J. Differential effect of environment enrichment and social isolation on depressive-like behavior, spontaneous activity and serotonin and norepinephrine concentration in prefrontal cortex and ventral striatum. Pharmacol Biochem Behav. 2008; 89: 85-93
    CrossrefPubMedGoogle Scholar
  • 11 Chapman AG, Croucher MJ, Meldrum BS. Anticonvulsant activity of intracerebro-ventricularly administered valproate and valproate analogues: a dose-dependent correlation with changes in brain aspartate and GABA levels in DBA/2 mice. Biochem Pharmacol. 1984; 33: 1459-63
    CrossrefPubMedGoogle Scholar
  • 12 Consoni FT, Vital MA, Andreatini R. Dual monoamine modulation for the antidepressant like effect of lamotrigine in the modified forced swimming test. Eur Neuropsychopharmacol. 2006; 16: 451-8
    CrossrefPubMedGoogle Scholar
  • 13 Cummings JL, Mega MS. Neuropsichiatria. Wyd Medyczne. Urban & Partner; 2003: 332-349
    PubMedGoogle Scholar
  • 14 Denicoff KD, Smith-Jackson ES, Bryan AL, Ali SO, Post RM. Valproate prophylaxis in a prospective clinical trial of refractory bipolar disorder. AmJ Psychiatry. 1996; 15: 1456-8
    PubMedGoogle Scholar
  • 15 Diamond MC, Krech D, Rosenzweig MR. The effects of an enriched environment on the histology of the rat cerebral cortex. J Comp Neurol. 1964; 123: 111-20
    CrossrefPubMedGoogle Scholar
  • 16 Diamond MC. Response of the brain to enrichment. An Acad Bras Cienc. 2001; 73 (2) 211-20
    PubMedGoogle Scholar
  • 17 Drapeau E, Mayo W, Aurousseau C, LeMoal M, Piazza PV, Abrous DN. Spatial memory performances of aged rats in the water maze predict levels of hippocampal neurogenesis. Proc Nat Acad Sci USA. 2003; 100: 14385-90
    CrossrefPubMedGoogle Scholar
  • 18 Drapeau E, Montaron MF, Aguerre S, Abrous DN. Learning-induced survival of new neurons depends on the cognitive status of aged rats. J Neurosc. 2007; 27: 6037-44
    CrossrefPubMedGoogle Scholar
  • 19 Dreifuss FE. Cognitive function: victim of disease or hostage to treatment?. Epilepsia. 1992; 33 (1) 7-12
    CrossrefPubMedGoogle Scholar
  • 20 Drhanushkodi A, Shetty AK. Is exposure to enriched environment beneficial for functional post-lesional recovery in temporal lobe epilepsy?. Neurosci Biobehav Rev. 2008; 32: 657-74
    CrossrefPubMedGoogle Scholar
  • 21 Faverjon S, Silveira DC, Fu DD, Cha BH, Akman C, Hu Y et al. Beneficial effects of enriched environment following status epilepticus in immature rats. Neurology 2002; 59 (9) 1302-3
    CrossrefPubMedGoogle Scholar
  • 22 Foley AG, Gallagher HC, Murphy KJ, Regan CM. Pentyl-4-yn-valproic acid reverses age-associated memory impairment in the Wistar rat. Neurobiol Aging. 2002; 24: 539-46
    PubMedGoogle Scholar
  • 23 Gholam KM, Meador KJ. Antiepileptic drugs and memory. Epilepsy Behav. 2004; 5: 435-9
    CrossrefPubMedGoogle Scholar
  • 24 Harding GF, Pullan JJ, Drasdo N. The effect of sodium valproate and other anticonvulsants on performance of children and adolescents. In: Parsonage MJ, Caldwell ADS. editors. The place of sodium valproate in the treatment of epilepsy. London: Academic Press; 1980: 61-71
    Google Scholar
  • 25 Hassan MN, Laljee HCK, Parsonage MG. Sodiumvalproate in the treatment of resistant epilepsy. Acta Neurol Scand. 1976; 4: 209-18
    PubMedGoogle Scholar
  • 26 Hattori S, Hashimoto R, Miyakawa T. Enriched environments influence depression-related behavior in adult mice and the survival of newborn cells in their hippocampi. Behav Brain Res. 2007; 180: 69-76
    CrossrefPubMedGoogle Scholar
  • 27 Isoherranen N, Yagen B, Bialer M. New CNS-active drugs which are second-generation valproic acid: can they lead to the development of a magic bullet?. Curr Opin Neurol. 2003; 16: 203-11
    CrossrefPubMedGoogle Scholar
  • 28 Johnston D. Valproic acid: update on its mechanism of action. Epilepsia. 1984; 25 (1) 14
    CrossrefPubMedGoogle Scholar
  • 29 Kempermann G, Kuhn HG, Gage FH. More hippocampal neurons in adult mice living in an enriched environment. Nature. 1997; 386: 493-5
    CrossrefPubMedGoogle Scholar
  • 30 Kempermann G, Kuhn HG, Gage FH. Experience-induced neurogenesis in the senescent dentate gyrus. J Neurosci. 1998; 18: 3206-12
    PubMedGoogle Scholar
  • 31 Kolb B, Gorny G, Soderpalm AH, Robinson TE. Environmental complexity has different effects on the structure of neurons in the prefrontal cortex versus the parietal cortex or nucleus accumbens. Synapse. 2003; 48 (3) 149-53
    CrossrefPubMedGoogle Scholar
  • 32 Kolb B, Whishaw IQ. Brain plasticity and behavior. Annu Rev Psychol. 1998; 49: 43-64
    CrossrefPubMedGoogle Scholar
  • 33 Larsson F, Winblad B, Mohammed AH. Psychological stress and environmental adaptation in enriched vs. impoverished housed rats. Pharmacol Biochem Behav. 2002; 73: 193-207
    CrossrefPubMedGoogle Scholar
  • 34 Leuner B, Gould E, Shors TJ. Is there a link between adult neurogenesis and learning?. Hippocampus. 2006; 16: 216-24
    CrossrefPubMedGoogle Scholar
  • 35 LÖsher W, Wahnschaffe U, HÖnack D, Wittfoht W, Nau H. Effects of valproate and E-2-en-valproate on functional and morphological parameters of rat liver: biochemical, histopathological and pharmacokinetic studies. Epilepsy Res. 1992; 13: 187-98
    CrossrefPubMedGoogle Scholar
  • 36 LÖsher W. Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy. CNS Drugs. 2002; 58 (1) 31-59
    PubMedGoogle Scholar
  • 37 Melendez RI, Gregory ML, Bardo MT, Kalivas PW. Impoverished rearing environment alters metabotropic glutamate receptor expression and function in the prefrontal cortex. Neuropsychopharmacoly. 2004; 9 (11) 1980-7
    PubMedGoogle Scholar
  • 38 Merrill DA, Karim R, Sarraq M, Chiba AA, Tuszynski MH. Hippocampal cell genesis does not correlate with spatial learning ability in aged rats. J Comp Neurol. 2003; 459: 201-7
    CrossrefPubMedGoogle Scholar
  • 39 Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods. 1984; 11: 47-60
    CrossrefPubMedGoogle Scholar
  • 40 Motamedi G, Meador K. Epilepsy and cognition. Epilepsy Behav. 2002; 4 (2) 25-38
    PubMedGoogle Scholar
  • 41 Murphy KJ, Fox GB, Foley AG, Gallagher HC, O’Connell A. Pentyl-4-yn-valproic acid enhances both spatial and avoidance learning, and attenuates age-related NCAM-mediated neuroplastic decline within the rat medial temporal lobe. J Neurochem. 2001; 78: 704-14
    CrossrefPubMedGoogle Scholar
  • 42 Nilsson M, Perfilieva E, Johansson U, Orwar O, Eriksson PS. Enriched environment increases neurogenesis in the adult rat dentate gyrus and improves spatial memory. J Neurobiol. 1999; 39: 569-78
    CrossrefPubMedGoogle Scholar
  • 43 Nithianantharajah J, Hannan AJ. Enriched environments, experience-dependent plasticity and disorders of the nervous system. Nat Rev Neurosci. 2006; 7: 697-709
    CrossrefPubMedGoogle Scholar
  • 44 Nowakowska E, Kokot Z. Wpływ leków normotymicznych na funkcje poznawcze. Postępy w leczeniu zaburzeń afektywnych, red. Nowakowska E, Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Pozna 2008: 66-88
    PubMedGoogle Scholar
  • 45 Olson AK, Eadie BD, Ernst C, Christie BR. Environmental enrichment and voluntary exercise massively increase neurogenesis in the adult hippocampus via dissociable pathways. Hippocampus. 2006; 16: 250-60
    CrossrefPubMedGoogle Scholar
  • 46 Perucca E, Aldenkamp A, Tallis R, Kramer G. Role of valproate across the ages: treatment of epilepsy in the elderly. Acta Neurol Scand. 2006; 114 (184) 28-37
    CrossrefPubMedGoogle Scholar
  • 47 Perucca E. Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience. CNS Drugs. 2002; 16: 695-714
    CrossrefPubMedGoogle Scholar
  • 48 Porsolt RD, Anton G, Blavet N, Jalfre M. Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol. 1978; 47: 379-91
    CrossrefPubMedGoogle Scholar
  • 49 Pużyński S. Pochodne kwasu walproinowego w terapii zaburzeń psychicznych, zwłaszcza chorób afektywnych. Psych Neurol. 2001; 10 (1) 25-34 Polish
    PubMedGoogle Scholar
  • 50 Rosenzweig MR, Bennett EL. Psychobiology of plasticity: effects of training and experience on brain and behavior. Behav Brain Res. 1996; 78: 57-65
    CrossrefPubMedGoogle Scholar
  • 51 Rosenzweig MR, Krech D, Bennett EL. Heredity, environment, brain biochemistry and learning. Current trends in psychological theory. Pittsburgh: University of Pittsburgh; 1961: 87-110
    Google Scholar
  • 52 Rostock A, Hoffmann W, Siegemund C, Bartsch R. Effects of carbamazepine, valproate calcium, clonazepam and piracetam on behavioral test methods for evaluation of memory-enhancing drugs. Methods Find Exp Clin Pharmacol. 1989; 11 (9) 547-53
    PubMedGoogle Scholar
  • 53 Thompson PJ, Trimble MR. Sodium valproate and cognitive functioning in normal volunteers. Br J Clin Pharmacol. 1981; 12: 819-24
    CrossrefPubMedGoogle Scholar
  • 54 Tomasiewicz HC, Mague SD, Cohen BM, Carlezon WA. Behavioral effects of short-term administration of lithium and valproic acid in rats. Brain Res. 2006; 8: 83-94
    PubMedGoogle Scholar
  • 55 Ueda S, Sakakibara S, Yoshimoto K. Effect of long-lasting serotonin depletion on environmental enrichment-induced neurogenesis in adult rat hippocampus and spatial learning. Neuroscience. 2005; 135: 395-402
    CrossrefPubMedGoogle Scholar
  • 56 Volzke E, Doose H. Dipropylacetate in the treatment of epilepsy. Epilepsia. 1973; 14: 185-93
    CrossrefPubMedGoogle Scholar
  • 57 Wagner GC, Kenneth C, Reuhl R, Cheh M, McRae P, Halladay AK. A new neurobehavioral model of autism in mice: pre- and postnatal exposure to sodiumvalproate. J Autism Dev Disord. 2006; 36: 779-93
    CrossrefPubMedGoogle Scholar
  • 58 Whitton PS, Flower LJ. The effect of valproic acid on 5-hy-droxytryptamine and 5-hydroxyindoleacetic acid concentration in hippocampal dialysates in vivo. Eur J Pharmacol. 1991; 200: 167-9
    CrossrefPubMedGoogle Scholar